Vaccine: X

Vaccine: X

疫苗:X

  • 3区 中科院分区
  • Q3 JCR分区

期刊简介

《Vaccine: X》是由Elsevier出版社创办的英文国际期刊(ISSN: 2590-1362),该期刊长期致力于免疫学领域的创新研究,主要研究方向为Multiple。作为SCIE收录期刊(JCR分区 Q3,中科院 3区),本刊采用OA未开放获取模式(OA占比1%),以发表免疫学领域等方向的原创性研究为核心(研究类文章占比96.12%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在129篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Vaccine: X审稿周期约为13 Weeks。该刊近年未被列入国际预警名单,年发文量约129篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 129 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
IMMUNOLOGY 免疫学 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
3区 3区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
IMMUNOLOGY 免疫学 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
4区 4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY ESCI Q3 128 / 183

30.3

学科:MEDICINE, RESEARCH & EXPERIMENTAL ESCI Q3 111 / 191

42.1

学科:IMMUNOLOGY ESCI Q3 119 / 183

35.25

学科:MEDICINE, RESEARCH & EXPERIMENTAL ESCI Q3 100 / 191

47.91

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY ESCI Q3 135 / 183

26.5

学科:MEDICINE, RESEARCH & EXPERIMENTAL ESCI Q3 109 / 195

44.4

学科:IMMUNOLOGY ESCI Q3 110 / 183

40.16

学科:MEDICINE, RESEARCH & EXPERIMENTAL ESCI Q3 99 / 195

49.49

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY ESCI Q3 120 / 181

34

学科:MEDICINE, RESEARCH & EXPERIMENTAL ESCI Q3 95 / 189

50

学科:IMMUNOLOGY ESCI Q3 91 / 181

50

学科:MEDICINE, RESEARCH & EXPERIMENTAL ESCI Q2 90 / 189

52.65

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:4.2 SJR:0.704 SNIP:0.731
学科类别 分区 排名 百分位
大类:Veterinary 小类:General Veterinary Q1 26 / 204

87%

大类:Veterinary 小类:Public Health, Environmental and Occupational Health Q2 236 / 725

67%

大类:Veterinary 小类:Infectious Diseases Q2 154 / 361

57%

大类:Veterinary 小类:General Immunology and Microbiology Q2 28 / 63

56%

大类:Veterinary 小类:Molecular Medicine Q3 122 / 179

32%

期刊发文

  • Comparison of seasonal influenza vaccine hesitancy among young adults at a Hong Kong university before and after the start of the COVID-19 pandemic: A repeated cross-sectional stud

    Author: Liang, Hongsen; Khairunnasa, Fatema; Yuan, Hsiang-Yu

    Journal: VACCINE: X. 2026; Vol. 29, Issue , pp. -. DOI: 10.1016/j.jvacx.2025.100774

  • Roles of stakeholders in the decision-making and health advocacy of human papillomavirus vaccination among children aged 9-14 year

    Author: Fu, Xiaoya; Zhang, Qian; Wang, Shenyu; Liu, Na; Wang, Xuwen; Guo, Xiang; Xia, Yilan; Lu, Yihan

    Journal: VACCINE: X. 2026; Vol. 28, Issue , pp. -. DOI: 10.1016/j.jvacx.2025.100776

  • Optimization and application of a mouse challenge model for Mumps viru

    Author: Zhang, Yajing; Chai, Benjie; Huang, Fei; Niu, Biao; Liu, Yangyang; Zhou, Pengpeng; Wang, Hui; Guo, Yue; Fu, Zhenfang; An, Qi; Tian, Dayong

    Journal: VACCINE: X. 2025; Vol. 25, Issue , pp. -. DOI: 10.1016/j.jvacx.2025.100665

  • Targeting age-appropriate adults' vaccine hesitancy to the herpes zoster vaccine in Ningbo, China: A latent profile analysi

    Author: Wang, Jianmei; Mei, Qiuhong; Zhou, Shaoying; Yang, Tianchi; Lyu, Mengqian; Feng, Yueyi; Wang, Zhaya; Hu, Lili; Huang, Bingqian; Ma, Rui

    Journal: VACCINE: X. 2025; Vol. 24, Issue , pp. -. DOI: 10.1016/j.jvacx.2025.100641

  • Antibody response after SARS-CoV-2 infection or vaccination in China: A cross-sectional stud

    Author: Zhu, Peng; Chen, Yan; Xu, Xia; Tan, Deyong; Xiao, Ledong; Liao, Chengling; Xia, Huan; Zhang, Ting; Zou, Jing; Chen, Xuan; Li, Man; Yang, Yang; Zhou, Jian; Liu, Jia; Zhang, Wei; Zhou, Honghao; Li, Qing

    Journal: VACCINE: X. 2025; Vol. 24, Issue , pp. -. DOI: 10.1016/j.jvacx.2025.100644

  • A discrete choice experiment on Chinese parents' preferences of vaccine schedules against six childhood infectious disease

    Author: Huang, Aodi; Tang, Lin; Huang, Lifang; Li, Jun; Zhang, Xue; Liu, Jiajie; Zhou, Yang; Zhang, Bingling; Wang, Lei; Zhang, Qian; Xu, Xia; Zhou, Zemei; Wang, Yu; Wang, Xiaoqi; Liu, Qianqian; Liu, Siyu; Yin, Zundong; Wang, Fuzhen

    Journal: VACCINE: X. 2025; Vol. 22, Issue , pp. -. DOI: 10.1016/j.jvacx.2024.100602